{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:56:02Z","timestamp":1769835362126,"version":"3.49.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1093\/jjco\/hyt012","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T20:55:07Z","timestamp":1360875307000},"page":"422-425","source":"Crossref","is-referenced-by-count":20,"title":["Successful EGFR-TKI Rechallenge of Leptomeningeal Carcinomatosis after Gefitinib-induced Interstitial Lung Disease"],"prefix":"10.1093","volume":"43","author":[{"given":"Shinji","family":"Nakamichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehito","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nokihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohide","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,2,13]]},"reference":[{"key":"key\n\t\t\t\t20170511081905_HYT012C1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511081905_HYT012C2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C3","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511081905_HYT012C4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"The National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511081905_HYT012C5","first-page":"772","article-title":"The results of gefitinib prospective investigation","volume":"41","author":"Yoshida","year":"2005","journal-title":"Med Drug J"},{"key":"key\n\t\t\t\t20170511081905_HYT012C6","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2005.04.9866","article-title":"Predictive factors for interstitial lung disease, antitumor response, and survival in non-small cell lung cancer patients treated with gefitinib","volume":"24","author":"Ando","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1743-7563.2007.00090.x","article-title":"Gefitinib in advanced non-small cell lung cancer: Clinical experience in patients of Asian origin","volume":"3","author":"Armour","year":"2007","journal-title":"Asia Pac J Clin Oncol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C8","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/rccm.200710-1501OC","article-title":"Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study","volume":"177","author":"Kudoh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170511081905_HYT012C9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/JTO.0b013e3181ca12e0","article-title":"Comparison of the Incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese patients with non-small cell lung cancer","volume":"5","author":"Hotta","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/JTO.0b013e3181d89ac2","article-title":"Successful treatment with erlotinib after gefitinib-induced severe interstitial lung disease","volume":"5","author":"Takeda","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/JTO.0b013e3181dc39cd","article-title":"Successful erlotinib rechallenge after gefitinib-induced acute interstitial pneumonia","volume":"5","author":"Chang","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00280-009-1212-5","article-title":"Successful rechallenge with erlotinib in a patient with EGFR mutant lung adenocarcinoma who developed gefitinib-related interstitial lung disease","volume":"65","author":"Fukui","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000332195","article-title":"Erlotinib achieved partial response in a non-small cell lung cancer patient with gefitinib-induced interstitial lung disease","volume":"4","author":"Qing","year":"2011","journal-title":"Case Rep Oncol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","article-title":"Leptomeningeal carcinomatosis","volume":"25","author":"Grossman","year":"1999","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t20170511081905_HYT012C15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/JTO.0b013e3181757a8b","article-title":"Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinoma","volume":"3","author":"Wagner","year":"2008","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20170511081905_HYT012C16","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/JTO.0b013e3181b62572","article-title":"Efficacy of erlotinib for brain and leptomeningeal metastasis in patients with lung adenocarcinoma who showed initial good response to gefitinib","volume":"4","author":"Katayama","year":"2009","journal-title":"J Thorac Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/43\/4\/422\/11686257\/hyt012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T09:43:59Z","timestamp":1503481439000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article-lookup\/doi\/10.1093\/jjco\/hyt012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,13]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,2,13]]},"published-print":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyt012","relation":{},"ISSN":["1465-3621","0368-2811"],"issn-type":[{"value":"1465-3621","type":"electronic"},{"value":"0368-2811","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,13]]}}}